ANXA1 was highlighted as a biomarker in oncology, and manipulation of ANX1 in cancers can influence the metastatic behavior of the tumor cells by modulating inflammation, immune response, and angiogenesis (Delorme et al., 2021). Here, ANXA1 is linked to neoplasm.